Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
Mark Crowther shared a noteworthy post honoring Dr. Davide Matino, faculty member of McMaster University Department of Medicine, on LinkedIn:
“Incredible breakthroughs are happening right here in Hamilton – and McMaster University is at the heart of it.
A promising new hemophilia treatment – described as “life-transforming”- is being tested on local patients, bringing hope to thousands across Canada.
Leading this cutting-edge clinical trial is Dr. Davide Matino, a faculty member in McMaster University Department of Medicine, which boasts decades of global research excellence in hemostasis and thrombosis.
This isn’t just a milestone in medicine-it’s a powerful reminder of the impact academic research can have when paired with compassion and collaboration.
McMaster’s Faculty of Health Sciences continues to lead the way in advancing care and improving lives, both locally and globally.”
Read more about this exciting development here.
Stay uptaded on hematology world news with Hemostasis Today:
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology